🔎 Trials Near Me

Utama › Kolitis Ulseratif › Wilayah Columbia › Washington

Kajian klinikal Kolitis Ulseratif di Washington, DC

12 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Immune Regulation in Ulcerative Colitis or Crohn s Disease

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
1 Day – 75 Years · Semua jantina · Dikemas kini 5 Okt 2026 · NCT00001184

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

Mengambil pesertaKajian pemerhatian
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Umur 18 hingga 85 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07619547

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Mengambil pesertaFasa 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT03816345

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Mengambil pesertaFasa 4
  • Capital Digestive Care, Chevy Chase · 8 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 3
  • Chevy Chase Clinical Research, Chevy Chase · 8 mi jauh
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Mengambil pesertaFasa 3
  • Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi jauh
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937086

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Mengambil pesertaFasa 4
  • Capital Digestive Care - MGG Group - Chevy Chase Clinical Research, Chevy Chase · 8 mi jauh
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 3
  • Mid-Atlantic GI Research, LLC - Site Number: 8400106, Greenbelt · 11 mi jauh
Umur 16 hingga 80 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Mengambil peserta
  • MedStar Georgetown University Hospital, Washington D.C.
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT05230173

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Mengambil pesertaKajian pemerhatian
  • MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase · 8 mi jauh
Umur 18 hingga 64 · Semua jantina · Dikemas kini 9 Jul 2026 · NCT06398626

Therapeutic Endpoint in Pediatric IBD Conditions

Mengambil pesertaKajian pemerhatian
  • Children's National Health System, Washington D.C.
Umur 6 hingga 21 · Semua jantina · Dikemas kini 8 Apr 2026 · NCT06065228

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Mengambil pesertaKajian pemerhatian
  • Capital Digestive Care, Chevy Chase · 8 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2025 · NCT06750731

Kajian Kolitis Ulseratif di bandar lain

Kajian lain di Washington

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.